Quoted: The University of Wisconsin-Madison joined the project last weekend and is expected to host one of the clinical trials.
The work in Madison will be led by William Hartman, UW Health assistant professor of anesthesiology. Hartman said Madison will be one of the clinical trial sites, though he could not say how many patients will participate.
“I think we can be very hopeful in that it has exhibited success with previous coronaviruses including SARS (Severe Acute Respiratory Syndrome),” Hartman said, referring to the use of survivor plasma.